Relapse in common lymphoma subtypes: salvage treatment options for follicular lymphoma, diffuse large cell lymphoma and Hodgkin disease

British Journal of Haematology
Bärbel SeyfarthNorbert Schmitz

Abstract

Over the last decade diagnostic techniques such as immunophenotyping as well as cytogenetic and molecular profiling gave new insights into the pathogenesis of malignant lymphoma and helped to establish the WHO classification. The recognition of well-defined biological entities with distinct response and relapse patterns led to the development of more specific treatment strategies for individual lymphoma subtypes. New treatment modalities such as the monoclonal antibody rituximab have improved the results of first-line treatment of patients with certain B-cell lymphoma subtypes substantially. Furthermore, new prognostic factors were described for different lymphoma entities leading to further differentiation of treatment. As a consequence, the quality of relapse after first-line therapy has changed and treatment strategies for relapsed disease need to be redefined. This review summarises current salvage treatment options for common lymphoma subtypes taking into account variables which should be considered before an individual patient is treated. We focus on follicular lymphoma, diffuse large B-cell lymphoma and Hodgkin disease since these are most frequent and evidence-based salvage strategies are beginning to emerge.

References

Feb 11, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D L LongoV T DeVita
Dec 1, 1991·The American Journal of Medicine·J O ArmitageD T Purtilo
Mar 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R J JonesS D Rowley
Aug 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G L PhillipsS N Wolff
Mar 1, 1987·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F CabanillasT Smith
Dec 6, 1984·The New England Journal of Medicine·S J Horning, S A Rosenberg
Jul 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M A RodriguezJ E Romaguera
Aug 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W H WilsonB D Cheson
Feb 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R ColwillA Keating
Mar 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W MillsA H Goldstone
Mar 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M G PfreundschuhR Kuse
Jun 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W S VelasquezF Cabanillas
Jun 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A Z RohatinerJ Matthews
Dec 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J E AndersonJ E Sanders
Nov 1, 1993·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P J BiermanJ O Armitage
Feb 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J L GajewskiM M Horowitz
Apr 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P McLaughlinF Cabanillas
Apr 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·N MilpiedA H Goldstone
Feb 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·V BonfanteG Bonadonna
Jul 1, 1997·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C GirouardM Crump
Oct 23, 1997·Hematology/oncology Clinics of North America·E J Rodriguez-Monge, F Cabanillas
Jul 8, 1998·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K TobinaiT Murate
Aug 15, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P McLaughlinB K Dallaire
Oct 21, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C GuglielmiF Chauvin
Mar 17, 1999·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M LazzarinoC Bernasconi
Oct 3, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J W FriedbergA S Freedman
Nov 30, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C H MoskowitzA D Zelenetz
Jul 13, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A SantoroV Diehl
Oct 2, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M S KaminskiJ M Vose
Jan 5, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J F SeymourR M Fox
Jan 5, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andreas JostingAndreas Engert
Jan 25, 2002·The New England Journal of Medicine·Bertrand CoiffierChristian Gisselbrecht

❮ Previous
Next ❯

Citations

Jan 31, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M KornackerP Dreger
May 7, 2010·Leukemia & Lymphoma·Mathias Witzens-Harig, Peter Dreger
Jan 24, 2007·Cancer Treatment Reviews·Matthew C CheungUNKNOWN Members of the Hematology, Disease Site Group of the Cancer Care Ontario Program in Evidence-Based Care
Oct 28, 2008·British Journal of Haematology·Christian Gisselbrecht
Aug 8, 2006·British Journal of Haematology·Miguel A CanalesFernando Hernandez-Navarro
Apr 3, 2012·World Journal of Gastrointestinal Oncology·Maria Christina CoxMassimo Marignani
Jan 27, 2009·Bone Marrow Transplantation·M HeizmannM J Bargetzi
Aug 22, 2018·Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion·Reena NairVivek Radhakrishnan

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.